Search research articles
Contact Us
Filters
Showing results (371-380 of 399) with videos related to
Page
of 40
Sort By:
British Journal of Cancer
|
September 24, 2009
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
C Pinto, F Di Fabio, C Barone, et al.
British Journal of Cancer
|
April 21, 2017
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
M A Calegari, A Inno, S Monterisi, et al.
Antimicrobial Resistance and Infection Control
|
June 5, 2021
The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study
V Baccolini, G Migliara, C Isonne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2014
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
A Santoro, V Gebbia, T Pressiani, et al.
European Journal of Pharmacology
|
August 11, 2000
Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke
C A Campbell, F C Barone, C D Benham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2015
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
C Cremolini, F Loupakis, C Antoniotti, et al.
British Journal of Cancer
|
January 14, 2012
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)
C Boni, M Tiseo, L Boni, et al.
Geroscience
|
June 21, 2025
The future of biomarkers for vascular contributions to cognitive impairment and dementia (VCID): proceedings of the 2025 annual workshop of the Albert research institute for white matter and cognition
Matthew J Lennon, Nikolaos Karvelas, Aravind Ganesh, et al.
Anticancer Research
|
May 29, 2008
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma
C Barone, R Grillo, D Dongiovanni, et al.
Plos One
|
October 29, 2019
Double triage to identify poorly annotated genes in maize: The missing link in community curation
Marcela K Tello-Ruiz, Cristina F Marco, Fei-Man Hsu, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 399) with videos related to
Sort By:
Page
of 40
British Journal of Cancer
|
September 24, 2009
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
C Pinto, F Di Fabio, C Barone, et al.
British Journal of Cancer
|
April 21, 2017
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
M A Calegari, A Inno, S Monterisi, et al.
Antimicrobial Resistance and Infection Control
|
June 5, 2021
The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study
V Baccolini, G Migliara, C Isonne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2014
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
A Santoro, V Gebbia, T Pressiani, et al.
European Journal of Pharmacology
|
August 11, 2000
Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke
C A Campbell, F C Barone, C D Benham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2015
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
C Cremolini, F Loupakis, C Antoniotti, et al.
British Journal of Cancer
|
January 14, 2012
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)
C Boni, M Tiseo, L Boni, et al.
Geroscience
|
June 21, 2025
The future of biomarkers for vascular contributions to cognitive impairment and dementia (VCID): proceedings of the 2025 annual workshop of the Albert research institute for white matter and cognition
Matthew J Lennon, Nikolaos Karvelas, Aravind Ganesh, et al.
Anticancer Research
|
May 29, 2008
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma
C Barone, R Grillo, D Dongiovanni, et al.
Plos One
|
October 29, 2019
Double triage to identify poorly annotated genes in maize: The missing link in community curation
Marcela K Tello-Ruiz, Cristina F Marco, Fei-Man Hsu, et al.
Page
of 40